{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "SARS-CoV-2", "TRPV4 channel", "amides/esters", "bioactive diterpenes", "labdane scaffold", "sclareolide", "structure-activity relationships"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "33081023", "DateCompleted": {"Year": "2020", "Month": "10", "Day": "28"}, "DateRevised": {"Year": "2020", "Month": "12", "Day": "18"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "10", "Day": "18"}], "Language": ["eng"], "ELocationID": ["519", "10.3390/md18100519"], "Journal": {"ISSN": "1660-3397", "JournalIssue": {"Volume": "18", "Issue": "10", "PubDate": {"Year": "2020", "Month": "Oct", "Day": "18"}}, "Title": "Marine drugs", "ISOAbbreviation": "Mar Drugs"}, "ArticleTitle": "Design, Synthesis and In Vitro Experimental Validation of Novel TRPV4 Antagonists Inspired by Labdane Diterpenes.", "Abstract": {"AbstractText": ["Labdane diterpenes are widespread classes of natural compounds present in variety of marine and terrestrial organisms and plants. Many of them represents \"natural libraries\" of compounds with interesting biological activities due to differently functionalized drimane nucleus exploitable for potential pharmacological applications. The transient receptor potential channel subfamily V member 4 (TRPV4) channel has recently emerged as a pharmacological target for several respiratory diseases, including the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Inspired by the labdane-like bicyclic core, a series of homodrimane-derived esters and amides was designed and synthesized by modifying the flexible tail in position 1 of (+)-sclareolide, an oxidized derivative of the bioactive labdane-type diterpene sclareol. The potency and selectivity towards rTRPV4 and hTRPV1 receptors were assessed by calcium influx cellular assays. Molecular determinants critical for eliciting TRPV4 antagonism were identified by structure-activity relationships. Among the selective TRPV4 antagonists identified, compound <b>6</b> was the most active with an IC<sub>50</sub> of 5.3 \u03bcM. This study represents the first report of semisynthetic homodrimane TRPV4 antagonists, selective over TRPV1, and potentially useful as pharmacological tools for the development of novel TRPV4 channel modulators."]}, "AuthorList": [{"Identifier": ["0000-0003-0029-7003"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Health and Nutritional Sciences, DoE 2018-2022, University of Calabria, Edificio Polifunzionale, 87036 Rende (CS), Italy."}, {"Identifier": [], "Affiliation": "Department of Organic and Medicinal Chemistry, Faculty of Pharmacy, University of Seville, Profesor Garc\u00eda Gonz\u00e1lez 2, 41071 Seville, Spain."}], "LastName": "Mazzotta", "ForeName": "Sarah", "Initials": "S"}, {"Identifier": ["0000-0002-1619-3295"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Health and Nutritional Sciences, DoE 2018-2022, University of Calabria, Edificio Polifunzionale, 87036 Rende (CS), Italy."}, {"Identifier": [], "Affiliation": "Department of Biotechnology, Chemistry and Pharmacy, DoE 2018-2022, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy."}], "LastName": "Carullo", "ForeName": "Gabriele", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Endocannabinoid Research Group (ERG), Institute of Biomolecular Chemistry, National Research Council (ICB-CNR), Via Campi Flegrei 34, 80078 Pozzuoli (NA), Italy."}, {"Identifier": [], "Affiliation": "Epitech Group SpA, 35030 Saccolongo (PD), Italy."}], "LastName": "Schiano Moriello", "ForeName": "Aniello", "Initials": "A"}, {"Identifier": ["0000-0002-6439-7575"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Biomolecular Chemistry, National Research Council (ICB-CNR), Via Campi Flegrei 34, 80078 Pozzuoli (NA), Italy."}], "LastName": "Amodeo", "ForeName": "Pietro", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Endocannabinoid Research Group (ERG), Institute of Biomolecular Chemistry, National Research Council (ICB-CNR), Via Campi Flegrei 34, 80078 Pozzuoli (NA), Italy."}, {"Identifier": [], "Affiliation": "Canada Excellence Research Chair on the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND)-Universit\u00e9 Laval, Qu\u00e9bec City, QC G1V 0A6, Canada."}], "LastName": "Di Marzo", "ForeName": "Vincenzo", "Initials": "V"}, {"Identifier": ["0000-0003-2197-2004"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Organic and Medicinal Chemistry, Faculty of Pharmacy, University of Seville, Profesor Garc\u00eda Gonz\u00e1lez 2, 41071 Seville, Spain."}], "LastName": "Vega-Holm", "ForeName": "Margarita", "Initials": "M"}, {"Identifier": ["0000-0001-9243-1307"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Biomolecular Chemistry, National Research Council (ICB-CNR), Via Campi Flegrei 34, 80078 Pozzuoli (NA), Italy."}], "LastName": "Vitale", "ForeName": "Rosa Maria", "Initials": "RM"}, {"Identifier": ["0000-0001-6846-5582"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Health and Nutritional Sciences, DoE 2018-2022, University of Calabria, Edificio Polifunzionale, 87036 Rende (CS), Italy."}], "LastName": "Aiello", "ForeName": "Francesca", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Chemistry and Pharmacy, DoE 2018-2022, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy."}], "LastName": "Brizzi", "ForeName": "Antonella", "Initials": "A"}, {"Identifier": ["0000-0002-6131-0470"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Endocannabinoid Research Group (ERG), Institute of Biomolecular Chemistry, National Research Council (ICB-CNR), Via Campi Flegrei 34, 80078 Pozzuoli (NA), Italy."}], "LastName": "De Petrocellis", "ForeName": "Luciano", "Initials": "L"}], "GrantList": [{"GrantID": "Dipartimento di Eccellenza grant 2018-2022", "Agency": "Ministero dell'Istruzione, dell'Universit\u00e0 e della Ricerca (Rome)", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Mar Drugs", "NlmUniqueID": "101213729", "ISSNLinking": "1660-3397"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Diterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "TRPV Cation Channels"}, {"RegistryNumber": "0", "NameOfSubstance": "TRPV4 protein, human"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Betacoronavirus"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": ["drug therapy", "virology"], "DescriptorName": "Coronavirus Infections"}, {"QualifierName": ["chemical synthesis", "pharmacology"], "DescriptorName": "Diterpenes"}, {"QualifierName": [], "DescriptorName": "Drug Design"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation"}, {"QualifierName": [], "DescriptorName": "HEK293 Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Inhibitory Concentration 50"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": [], "DescriptorName": "Pandemics"}, {"QualifierName": ["drug therapy", "virology"], "DescriptorName": "Pneumonia, Viral"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "TRPV Cation Channels"}], "CoiStatement": "The authors declare no conflict of interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Singh M., Pal M., Sharma R.P. Biological activity of the labdane diterpenes. Planta Med. 1999;65:2\u20138. doi: 10.1055/s-1999-13952.", "ArticleIdList": ["10.1055/s-1999-13952", "10083836"]}, {"Citation": "Pal M., Mishra T., Kumar A., Tewari S.K. Medicinal plants: Biological evaluation of terrestrial and marine plant originated labdane diterpenes (a review) Pharm. Chem. J. 2016;50:558\u2013567. doi: 10.1007/s11094-016-1490-2.", "ArticleIdList": ["10.1007/s11094-016-1490-2"]}, {"Citation": "Aiello F., Carullo G., Badolato M., Brizzi A. TRPV1\u2013FAAH\u2013COX: The Couples Game in Pain Treatment. ChemMedChem. 2016;11:1686\u20131694. doi: 10.1002/cmdc.201600111.", "ArticleIdList": ["10.1002/cmdc.201600111", "27240888"]}, {"Citation": "Premkumar L.S. Transient receptor potential channels as targets for phytochemicals. ACS Chem. Neurosci. 2014;5:1117\u20131130. doi: 10.1021/cn500094a.", "ArticleIdList": ["10.1021/cn500094a", "PMC4240255", "24926802"]}, {"Citation": "Vitale R.M., Schiano Moriello A., De Petrocellis L. Natural compounds and synthetic drugs targeting the ionotropic cannabinoid members of transient receptor potential (TRP) channels. In: Maccarrone M., editor. New Tools to Interrogate Endocannabinoid Signalling\u2014From Natural Compounds to Synthetic Drugs. RSC; London, UK: 2020. in press."}, {"Citation": "Liedtke W., Choe Y., Mart\u00ed-Renom M.A., Bell A.M., Denis C.S., \u0160ali A., Hudspeth A.J., Friedman J.M., Heller S. Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor. Cell. 2000;103:525\u2013535. doi: 10.1016/S0092-8674(00)00143-4.", "ArticleIdList": ["10.1016/S0092-8674(00)00143-4", "PMC2211528", "11081638"]}, {"Citation": "Strotmann R., Harteneck C., Nunnenmacher K., Schultz G., Plant T.D. OTRPC4, a nonselective cation channel that confers sensivity to extracellular osmolarity. Nat. Cell Biol. 2000;2:695\u2013702. doi: 10.1038/35036318.", "ArticleIdList": ["10.1038/35036318", "11025659"]}, {"Citation": "Deng Z., Paknejad N., Maksaev G., Sala-Rabanal M., Nichols C.G., Hite R.K., Yuan P. Cryo-EM and X-ray structures of TRPV4 reveal insight into ion permeation and gating mechanisms. Nat. Struct. Mol. Biol. 2018;25:252\u2013260. doi: 10.1038/s41594-018-0037-5.", "ArticleIdList": ["10.1038/s41594-018-0037-5", "PMC6252174", "29483651"]}, {"Citation": "Kuebler W.M., Jordt S.E., Liedtke W.B. Urgent reconsideration of lung edema as a preventable outcome in COVID-19: Inhibition of TRPV4 represents a promising and feasible approach. Am. J. Physiol. Lung Cell. Mol. Physiol. 2020;318:L1239\u2013L1243. doi: 10.1152/ajplung.00161.2020.", "ArticleIdList": ["10.1152/ajplung.00161.2020", "PMC7276984", "32401673"]}, {"Citation": "Jian M.Y., King J.A., Al-Mehdi A.B., Liedtke W., Townsley M.I. High vascular pressure-induced lung injury requires P450 epoxygenase-dependent activation of TRPV4. Am. J. Respir. Cell Mol. Biol. 2008;38:386\u2013392. doi: 10.1165/rcmb.2007-0192OC.", "ArticleIdList": ["10.1165/rcmb.2007-0192OC", "PMC2274943", "17962608"]}, {"Citation": "Vincent F., Duncton M.A.J. TRPV4 Agonists and Antagonists. Curr. Top. Med. Chem. 2011;11:2216\u20132226. doi: 10.2174/156802611796904861.", "ArticleIdList": ["10.2174/156802611796904861", "21671873"]}, {"Citation": "Lawhorn B.G., Brnardic E.J., Behm D.J. Recent advances in TRPV4 agonists and antagonists. Bioorg. Med. Chem. Lett. 2020;30:127022. doi: 10.1016/j.bmcl.2020.127022.", "ArticleIdList": ["10.1016/j.bmcl.2020.127022", "32063431"]}, {"Citation": "Smith P.L., Maloney K.N., Pothen R.G., Clardy J., Clapham D.E. Bisandrographolide from Andrographis paniculata activates TRPV4 channels. J. Biol. Chem. 2006;281:29897\u201329904. doi: 10.1074/jbc.M605394200.", "ArticleIdList": ["10.1074/jbc.M605394200", "16899456"]}, {"Citation": "Hilfiker M.A., Hoang T.H., Cornil J., Eidam H.S., Matasic D.S., Roethke T.J., Klein M., Thorneloe K.S., Cheung M. Optimization of a novel series of TRPV4 antagonists with in vivo activity in a model of pulmonary edema. ACS Med. Chem. Lett. 2013;4:293\u2013296. doi: 10.1021/ml300449k.", "ArticleIdList": ["10.1021/ml300449k", "PMC4027501", "24900661"]}, {"Citation": "Cheung M., Bao W., Behm D.J., Brooks C.A., Bury M.J., Dowdell S.E., Eidam H.S., Fox R.M., Goodman K.B., Holt D.A., et al. Discovery of GSK2193874: An Orally Active, Potent, and Selective Blocker of Transient Receptor Potential Vanilloid 4. ACS Med. Chem. Lett. 2017;8:549\u2013554. doi: 10.1021/acsmedchemlett.7b00094.", "ArticleIdList": ["10.1021/acsmedchemlett.7b00094", "PMC5430398", "28523109"]}, {"Citation": "Lin Z., Phadke S., Lu Z., Beyhan S., Abdel Aziz M.H., Reilly C., Schmidt E.W. Onydecalins, Fungal Polyketides with Anti- Histoplasma and Anti-TRP Activity. J. Nat. Prod. 2018;81:2605\u20132611. doi: 10.1021/acs.jnatprod.7b01067.", "ArticleIdList": ["10.1021/acs.jnatprod.7b01067", "PMC6474802", "30507122"]}, {"Citation": "Chakraborty K., Lipton A.P., Paul Raj R., Vijayan K.K. Antibacterial labdane diterpenoids of Ulva fasciata Delile from southwestern coast of the Indian Peninsula. Food Chem. 2010;119:1399\u20131408. doi: 10.1016/j.foodchem.2009.09.019.", "ArticleIdList": ["10.1016/j.foodchem.2009.09.019"]}, {"Citation": "P\u00e9rez-Garc\u00eda E., Zub\u00eda E., Ortega M.J., Carballo J.L. Merosesquiterpenes from two sponges of the genus Dysidea. J. Nat. Prod. 2005;68:653\u2013658. doi: 10.1021/np040237z.", "ArticleIdList": ["10.1021/np040237z", "15921404"]}, {"Citation": "Caniard A., Zerbe P., Legrand S., Cohade A., Valot N., Magnard J.L., Bohlmann J., Legendre L. Discovery and functional characterization of two diterpene synthases for sclareol biosynthesis in Salvia sclarea (L.) and their relevance for perfume manufacture. BMC Plant. Biol. 2012;12:1\u201313. doi: 10.1186/1471-2229-12-119.", "ArticleIdList": ["10.1186/1471-2229-12-119", "PMC3520730", "22834731"]}, {"Citation": "Coricello A., El-Magboub A., Luna M., Ferrario A., Haworth I.S., Gomer C.J., Aiello F., Adams J.D. Rational drug design and synthesis of new \u03b1-Santonin derivatives as potential COX-2 inhibitors. Bioorg. Med. Chem. Lett. 2018;28:993\u2013996. doi: 10.1016/j.bmcl.2018.02.036.", "ArticleIdList": ["10.1016/j.bmcl.2018.02.036", "29501395"]}, {"Citation": "Coricello A., Adams J.D., Lien E.J., Nguyen C., Perri F., Williams T.J., Aiello F. A Walk in Nature: Sesquiterpene Lactones as Multi-Target Agents Involved in Inflammatory Pathways. Curr. Med. Chem. 2018;27:1501\u20131514. doi: 10.2174/0929867325666180719111123.", "ArticleIdList": ["10.2174/0929867325666180719111123", "30027844"]}, {"Citation": "Chen Q., Tang K., Guo Y. Discovery of sclareol and sclareolide as filovirus entry inhibitors. J. Asian Nat. Prod. Res. 2020;22:464\u2013473. doi: 10.1080/10286020.2019.1681407.", "ArticleIdList": ["10.1080/10286020.2019.1681407", "31738086"]}, {"Citation": "Dixon D.D., Lockner J.W., Zhou Q., Baran P.S. Scalable, divergent synthesis of meroterpenoids via \u201cborono-sclareolide\u201d. J. Am. Chem. Soc. 2012;134:8432\u20138435. doi: 10.1021/ja303937y.", "ArticleIdList": ["10.1021/ja303937y", "22583115"]}, {"Citation": "Li D., Zhang S., Song Z., Wang G., Li S. Bioactivity-guided mixed synthesis accelerate the serendipity in lead optimization: Discovery of fungicidal homodrimanyl amides. Eur. J. Med. Chem. 2017;136:114\u2013121. doi: 10.1016/j.ejmech.2017.04.073.", "ArticleIdList": ["10.1016/j.ejmech.2017.04.073", "28486209"]}, {"Citation": "Koga T., Aoki Y., Hirose T., Nohira H. Resolution of sclareolide as a key intermediate for the synthesis of Ambrox\u00ae. Tetrahedron Asymmetry. 1998;9:3819\u20133823. doi: 10.1016/S0957-4166(98)00404-2.", "ArticleIdList": ["10.1016/S0957-4166(98)00404-2"]}, {"Citation": "Aiello F., Badolato M., Pessina F., Sticozzi C., Maestrini V., Aldinucci C., Luongo L., Guida F., Ligresti A., Artese A., et al. Design and Synthesis of New Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channel Modulators: Identification, Molecular Modeling Analysis, and Pharmacological Characterization of the N-(4-Hydroxy-3-methoxybenzyl)-4-(thiophen-2-yl)butanamide. ACS Chem. Neurosci. 2016;7:737\u2013748. doi: 10.1021/acschemneuro.5b00333.", "ArticleIdList": ["10.1021/acschemneuro.5b00333", "26942555"]}, {"Citation": "Schiano Moriello A., De Petrocellis L. Endocannabinoid Signaling: Methods and Protocols. Volume 1412. Springer; Berlin/Heidelberg, Germany: 2016."}, {"Citation": "Thorneloe K.S., Sulpizio A.C., Lin Z., Figueroa D.J., Clouse A.K., McCafferty G.P., Chendrimada T.P., Lashinger E.S.R., Gordon E., Evans L., et al. N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino} -3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urin. J. Pharmacol. Exp. Ther. 2008;326:432\u2013442. doi: 10.1124/jpet.108.139295.", "ArticleIdList": ["10.1124/jpet.108.139295", "18499743"]}, {"Citation": "Iannotti F.A., De Maio F., Panza E., Appendino G., Taglialatela-Scafati O., De Petrocellis L., Amodeo P., Vitale R.M. Identification and Characterization of Cannabimovone, a Cannabinoid from Cannabis sativa, as a Novel PPAR Agonist via a Combined Computational and Functional Study. Molecules. 2020;25:1119. doi: 10.3390/molecules25051119.", "ArticleIdList": ["10.3390/molecules25051119", "PMC7179127", "32138197"]}]}], "History": [{"Year": "2020", "Month": "9", "Day": "3"}, {"Year": "2020", "Month": "10", "Day": "12"}, {"Year": "2020", "Month": "10", "Day": "14"}, {"Year": "2020", "Month": "10", "Day": "21", "Hour": "1", "Minute": "2"}, {"Year": "2020", "Month": "10", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "10", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "10", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["33081023", "PMC7594054", "10.3390/md18100519", "md18100519"]}}]}